262 related articles for article (PubMed ID: 28116591)
1. PRISM, a Patient-Reported Outcome Instrument, Accurately Measures Symptom Change in Refractory Gastroesophageal Reflux Disease.
Fuller G; Bolus R; Whitman C; Talley J; Erder MH; Joseph A; Silberg DG; Spiegel B
Dig Dis Sci; 2017 Mar; 62(3):593-606. PubMed ID: 28116591
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a patient-reported outcome instrument in partial responders to proton pump inhibitors.
Rydén A; Denison H; Karlsson M; Vakil N
Scand J Gastroenterol; 2013 Sep; 48(9):1018-26. PubMed ID: 23919738
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a simple and multifaceted instrument, GERD-TEST, for the clinical evaluation of gastroesophageal reflux and dyspeptic symptoms.
Nakada K; Matsuhashi N; Iwakiri K; Oshio A; Joh T; Higuchi K; Haruma K
World J Gastroenterol; 2017 Jul; 23(28):5216-5228. PubMed ID: 28811716
[TBL] [Abstract][Full Text] [Related]
4. Validation of a short questionnaire in English and French for use in patients with persistent upper gastrointestinal symptoms despite proton pump inhibitor therapy: the PASS (Proton pump inhibitor Acid Suppression Symptom) test.
Armstrong D; Veldhuyzen SJ; Chung SA; Shapiro CM; Dhillon S; Escobedo S; Chakraborty BK; Mann V; Tanser L; Nevin K
Can J Gastroenterol; 2005 Jun; 19(6):350-8. PubMed ID: 15997268
[TBL] [Abstract][Full Text] [Related]
5. Systematic review of patient-reported outcome instruments for gastroesophageal reflux disease symptoms.
Vakil NB; Halling K; Becher A; Rydén A
Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):2-14. PubMed ID: 23202695
[TBL] [Abstract][Full Text] [Related]
6. Validation of the reflux symptom questionnaire electronic diary in partial responders to proton pump inhibitor therapy.
Vakil N; Björck K; Denison H; Halling K; Karlsson M; Paty J; Silberg DG; Rydén A
Clin Transl Gastroenterol; 2012 Jan; 3(1):e7. PubMed ID: 23238029
[TBL] [Abstract][Full Text] [Related]
7. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
Schey R; Alla SP; Midani D; Parkman HP
Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
[TBL] [Abstract][Full Text] [Related]
8. Evaluation and Validation of the Modified Reflux Symptom Questionnaire-Electronic Diary in Patients With Persistent Gastroesophageal Reflux Disease.
Andrae DA; Hanlon J; Cala ML; Scippa K; Graham C; Witherspoon B; Shao JZ; Reasner D
Clin Transl Gastroenterol; 2020 Jan; 11(1):e00117. PubMed ID: 31977454
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
10. Night-time symptoms and their impact on sleep in patients with gastroesophageal reflux disease who have a partial response to proton pump inhibitors: a qualitative patient interview study.
Rydén A; Martin M; Halling K; Niklasson A
Patient; 2013; 6(4):307-14. PubMed ID: 23990378
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of gastroesophageal reflux disease symptoms and effects of esomeprazole on the quality of life related to reflux and dyspepsia in patients on maintenance hemodialysis.
Namikoshi T; Harada K; Hatta H; Tokura T; Oshiro Y; Nishizaki T; Obata T; Mori M; Fueki T; Fujimoto S; Haruna Y; Kuwabara A; Yorimitsu D; Ihoriya C; Kadoya H; Itano S; Fujimoto Y; Komai N; Sasaki T; Kashihara N
Clin Exp Nephrol; 2016 Feb; 20(1):134-42. PubMed ID: 26026991
[TBL] [Abstract][Full Text] [Related]
12. Look--but also listen! ReQuest: an essay on a new validated scale to assess the outcome of GERD treatment.
Bardhan KD; Berghöfer P
Digestion; 2007; 75 Suppl 1():87-100. PubMed ID: 17489037
[TBL] [Abstract][Full Text] [Related]
13. Nissen fundoplication
Zhang C; Hu ZW; Yan C; Wu Q; Wu JM; Du X; Liu DG; Luo T; Li F; Wang ZG
World J Gastroenterol; 2017 May; 23(19):3546-3555. PubMed ID: 28596691
[TBL] [Abstract][Full Text] [Related]
14. [Cross-cultural adaptation and validation for Portuguese (Brazil) of health related quality of life instruments specific for gastroesophageal reflux disease].
Pereira GI; Costa CD; Geocze L; Borim AA; Ciconelli RM; Camacho-Lobato L
Arq Gastroenterol; 2007; 44(2):168-77. PubMed ID: 17962865
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy?
Takeuchi T; Oota K; Harada S; Edogawa S; Kojima Y; Sanomura M; Sakaguchi M; Hayashi K; Hongoh Y; Itabashi T; Kitae H; Hoshimoto M; Takeuchi N; Higuchi K
Intern Med; 2015; 54(2):97-105. PubMed ID: 25742999
[TBL] [Abstract][Full Text] [Related]
16. A Modular Health-Related Quality of Life Instrument for Electronic Assessment and Treatment Monitoring: Web-Based Development and Psychometric Validation of Core Thrive Items.
Wicks P; McCaffrey S; Goodwin K; Black R; Hoole M; Heywood J
J Med Internet Res; 2019 Jan; 21(1):e12075. PubMed ID: 30681962
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a disease-specific quality of life questionnaire for gastro-oesophageal reflux disease: the GERD-QOL questionnaire.
Chan Y; Ching JY; Cheung CM; Tsoi KK; Polder-Verkiel S; Pang SH; Quan WL; Kee KM; Chan FK; Sung JJ; Wu JC
Aliment Pharmacol Ther; 2010 Feb; 31(3):452-60. PubMed ID: 19878152
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of the Diabetic Peripheral Neuropathic Pain Impact (DPNPI) measure, a patient-reported outcome measure.
Brod M; Blum SI; Bushnell DM; Ramasamy A
Qual Life Res; 2015 Dec; 24(12):3001-14. PubMed ID: 26068732
[TBL] [Abstract][Full Text] [Related]
19. The suitability of the GERDyzer instrument in pH-test-proven laryngopharyngeal reflux patients.
Wu CP; Liang WM; Wang CC; Chang CS; Yeh HZ; Hsu JY; Ko CW; Lee SW; Chang SC; Sung FC; Lien HC
Medicine (Baltimore); 2016 Aug; 95(31):e4439. PubMed ID: 27495070
[TBL] [Abstract][Full Text] [Related]
20. Unmet treatment needs of gastroesophageal reflux disease in Asia: gastroesophageal reflux disease in Asia Pacific survey.
Goh KL; Choi MG; Hsu WP; Chun HJ; Mahachai V; Kachintorn U; Leelakusolvong S; Kim N; Rani AA; Wong BC; Wu J; Chiu CT; Chu R; Shetty V; Bocobo JC; Chan MM; Lin JT
J Gastroenterol Hepatol; 2014 Dec; 29(12):1969-75. PubMed ID: 24990817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
